SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.


Contact Us >>

Article citations


Shimizu, S. (2015) Development of Anti-Cancer Drugs Mediated by Apoptosis and Autophagy. Nihon Rinsho, 73, 1302-1307.

has been cited by the following article:

  • TITLE: Cancer Is Treatable via the Alternative Cellular Energy (ACE) Pathway

    AUTHORS: W. John Martin

    KEYWORDS: Cancer, ACE Pathway, KELEA, Enerceuticals, Stealth Adapted Viruses, Apoptosis, Homeopathy, Orgone, HANSI, Enercel, Dipolar, Herpes, Autism, Phototherapy

    JOURNAL NAME: Journal of Cancer Therapy, Vol.8 No.13, December 28, 2017

    ABSTRACT: Energy is required for cell replication, differentiation and specialized cellular processes, including cell death from apoptosis. The alternative cellular energy (ACE) pathway is an additional source of cellular energy beyond that obtained from the metabolism of food. The added energy is presumptively derived from an environment force defined as KELEA (kinetic energy limiting electrostatic attraction). The ACE pathway is expressed as a dynamic (kinetic) activity of the body’s fluids that can seemingly facilitate biochemical reactions. Cancer is viewed as a metabolic derangement in genetically altered cells, in which the tumor cells have sufficient energy to replicate but insufficient cellular energy (ICE) to undergo preemptive apoptosis. Empirical observations are consistent with the premise that supplying additional cellular energy via the ACE pathway can enable tumor cells to undergo more timely apoptosis. The body’s ACE pathway can be enhanced by administering either KELEA activated water or KELEA attracting compounds, referred to as enerceuticalsTM. Increased levels of KELEA can also be created using various devices, which attract and subsequently transfer KELEA to the body or to water for subsequent administration. Several KELEA attracting devices operate by repetitive on-off electrical switching, while others involve the convergence of intermittent light paths. The fluctuating electrical activity of the brain is proposed to function as a variable antenna for bringing KELEA into the body. Preliminary evidence suggests that ACE pathway based interventional therapies may improve this presumed KELEA antenna function of the brain, leading to a sustainable improvement in the patient’s ACE pathway. It is proposed that cancers are treatable and probably also preventable using methods to enhance the ACE pathway. Such methods may include the routine drinking of KELEA activated water.